Clinical manifestations of the anti-phospholipid syndrome as defined by the updated Sapporo classification criteria | Annals of the Rheumatic Diseases

Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Archive
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals More

You are viewing from: Department GEZ-LTA Erasmushogeschool

Article info

Letter

Clinical manifestations of the anti-phospholipid syndrome as defined by the updated Sapporo classification criteria

Authors

Jesse Drijkoningen PubMed articles Google scholar articles
Jan Damoiseaux PubMed articles Google scholar articles
Pieter van Paassen PubMed articles Google scholar articles
Jan Willem Cohen Tervaert PubMed articles Google scholar articles

Jan Damoiseaux, Ph.D., Department of Clinical and Experimental Immunology, University Hospital Maastricht, PO Box 5800, 6202 AZ Maastricht, The Netherlands; jdam{at}limm.azm.nl

Citation

Drijkoningen J, Damoiseaux J, van Paassen P, et al

Clinical manifestations of the anti-phospholipid syndrome as defined by the updated Sapporo classification criteria

Annals of the Rheumatic Diseases 2007;66:1407-1408.

Publication history

Accepted February 4, 2007
First published September 19, 2007.

Online issue publication

April 13, 2016

Copyright information

2007 BMJ Publishing Group Ltd and European League Against Rheumatism